Journal Articles
Multidisciplinary treatment for hepatocellular carcinoma beyond drug therapy
Lead Editor:
-
Dr Toru Ishikawa
Saiseikai Niigata Hospital
Japan
Currently, drug therapy, including combined immunotherapy, is the main treatment for hepatocellular carcinoma. However, it is effective in cases classified as Child Pugh A. In actual clinical practice, this is not necessarily a Child Pugh A population. In this theme, we would like to consider multidisciplinary treatment including drug therapy.
Submission deadline: 10/10/2024
